(Q51996966)

English

5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease.

scientific article published in November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

Sebastiaan Engelborghs

1

object named as

Sebastiaan Engelborghs

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

author name string

Clive Holmes

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

Michelle McCulley

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

Peter P De Deyn

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

19

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

11

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

1108-1109

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1179

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1179

7 January 2021

based on heuristic

inferred from DOI database lookup

5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1179

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1179

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.1179

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/15497194

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51996966&oldid=1453777189"